Health Informatics
828 articles · 19 journals
Journals in this subcategory (19)
- ESMO Real World Data and Digital Oncology · Elsevier (95)
- Medical Image Analysis · Elsevier (90)
- Intelligence-Based Medicine · Elsevier (80)
- Internet Interventions · Elsevier (76)
- Preventive Medicine Reports · Elsevier (75)
- Computers in Biology and Medicine · Elsevier (64)
- International Journal of Medical Informatics · Elsevier (64)
- Computer Methods and Programs in Biomedicine · Elsevier (60)
- European Journal of Radiology Artificial Intelligence · Elsevier (43)
- Artificial Intelligence in Medicine · Elsevier (39)
- Computerized Medical Imaging and Graphics · Elsevier (34)
- Informatics in Medicine Unlocked · Elsevier (29)
- Journal of Biomedical Informatics · Elsevier (27)
- Digital Chinese Medicine · Elsevier (24)
- Current Protocols · Wiley (20)
- Annals of 3D Printed Medicine · Elsevier (8)
- Implementation Science · Springer Nature (0)
- Journal of NeuroEngineering and Rehabilitation · Springer Nature (0)
- npj Imaging · Springer Nature (0)
- Tools and architectures for agentic systems in clinical AI and radiology
- Test-set composition and the interpretation of biopsy reduction in AI-guided breast MRI
- Corrigendum to Deep learning reconstruction for prostate MRI: Impact of field-of-view selection on global and regional image quality [Eur. J. Radiol. Artif. Intell., volume 2 (2025): 100017]
- Erratum to “In prostate cancer diagnosis, deep learning model’s performance declines as MRI quality reduces, while radiologists’ performance remains the same” [Eur. J. Radiol. Artif. Intell. 6 (2026), 100084]
- Erratum to “Using ensemble radiomic models to identify uncertainty in lung nodule classifications, 2025/10/22,” [Eur. J. Radiol. Artif. Intell., Pages:100047]
- Erratum to “External validation of automated prostate MR T2-weighted image quality assessment on multi-centre multi-vendor data" [Eur. J. Radiol. Artif. Intell. 1 (2025) 100002]
- 362P A digital twin framework for synthetic control arm generation: A proof-of-concept assessment of the phase III ECHO trial intervention cohort
- 363P Generation of synthetic patient survival data from trial-level metadata using machine learning
- 364P Beyond treatment assignment: Evaluating longitudinal oncology strategies using real-world cancer registry data
- 365P Population impact of national DPYD commissioning on severe fluoropyrimidine-related harm in England: Interrupted time-series and self-controlled case-series analyses using linked routine data
- 366P Patient perspectives on artificial intelligence in cancer care and needs for education and transparency
- 367P Trust in artificial intelligence for chemotherapy decision-making: A scenario-based cross-sectional surveyinformed by previous cancer treatment history
- 368P Large language model-assisted writing in oncology: A bibliometric analysis of signaling word trends across ESMO conferences
- 369P Artificial intelligence content at the ESMO Congress 2021–2025: Prevalence, application domains, validation level and geography
- 370P A multi-dimension audit of generative AI oncology trials: Implications for design and reporting
- 371eP From multiparametric MRI to precision segmentation: An automated framework for accurate brain tumor delineation
- 372eP A single multimodal survival model robust to missing modalities: Intermediate fusion of foundation model embeddings in a pan-cancer TCGA cohort
- 373eP Mapping global authorship networks in phase 3 cancer trials Using the Geographic Complexity Index (GCI)
- 374eP Conflict of interest reporting for editors and boards of oncology journals: A cross-sectional analysis
- Artificial intelligence in oncology: from isolated task-specific tools toward integrated decision support systems
- Reply to “Beyond pairwise comparisons of androgen receptor signaling inhibitors in nonmetastatic castration-resistant prostate cancer”
- Beyond pairwise comparisons of androgen receptor signaling inhibitors in nonmetastatic castration-resistant prostate cancer
- Clinical and genomic determinants of early treatment discontinuation in non-small-cell lung cancer: an analysis of the AACR Project GENIE Biopharma Collaborative NSCLC dataset
- Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia
- Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre
- Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study
- From electronic health records to real-world evidence: Savana Next-Generation Registry digital solution
- Neoadjuvant versus adjuvant chemotherapy in luminal B-like breast cancer: a subset analysis of the CANTO study
- Adjuvant olaparib for patients with germline BRCA-mutated, high-risk, HER2-negative early breast cancer: real-world data from a French early access program☆
- Skin toxicity and effectiveness of first-line enfortumab vedotin plus pembrolizumab for urothelial carcinoma: a prospective multicenter real-world study in Japan